Stock Analysis

B-R 31 Ice CreamLtd Full Year 2024 Earnings: EPS: JP¥160 (vs JP¥125 in FY 2023)

TSE:2268
Source: Shutterstock

B-R 31 Ice CreamLtd (TSE:2268) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥30.7b (up 24% from FY 2023).
  • Net income: JP¥1.54b (up 28% from FY 2023).
  • Profit margin: 5.0% (up from 4.9% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: JP¥160 (up from JP¥125 in FY 2023).
    earnings-and-revenue-history
    TSE:2268 Earnings and Revenue History February 13th 2025

    All figures shown in the chart above are for the trailing 12 month (TTM) period

    B-R 31 Ice CreamLtd's share price is broadly unchanged from a week ago.

    Balance Sheet Analysis

    While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on B-R 31 Ice CreamLtd's balance sheet.

    Valuation is complex, but we're here to simplify it.

    Discover if B-R 31 Ice CreamLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

    Access Free Analysis

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:2268

B-R 31 Ice CreamLtd

Manufactures, imports, exports, and sells ice cream and related products.

Excellent balance sheet and fair value.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor